Science to Consumers, Inc. (BEUT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | -47.69 Thousand |
| Net Income | - | - | - | - | - | -58.7 Thousand |
| Depreciation & Amortization | - | - | - | - | - | 2032.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | 8980.00 |
| Other non-cash items | - | - | - | - | - | -4916.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | 49.25 Thousand |
| Debt repayment | - | - | - | - | - | -36.1 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 13.14 Thousand |
| Other Financing Activities | - | - | - | - | - | 49.25 Thousand |
| Accounts receivables | - | - | - | - | - | 2575.00 |
| Accounts payables | - | - | - | - | - | 6405.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | 2575.00 |
| Cash at beginning of period | - | - | - | - | - | 1749.00 |
| Cash at end of period | - | - | - | - | - | 3306.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | 1557.00 |
| Free Cash Flow | - | - | - | - | - | -47.69 Thousand |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY | 2016 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | -19.19 Thousand |
| Depreciation & Amortization | - | - | - | - | - | 871.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | 7762.00 |
| Other non-cash items | - | - | - | - | - | 9126.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | 0.03 |
| Cash at beginning of period | - | - | - | - | - | 1435.00 |
| Cash at end of period | - | - | - | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | -1435.00 |
| Free Cash Flow | - | - | - | - | - | -1435.00 |
AFG
3571
PBL
TOGOF
ONB
ONT